Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H MacCabe

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|April 25, 2012
Advancing maternal age is associated with increasing risk for autism: a review and meta-analysisSven Sandin, Christina M Hultman, Alexander Kolevzon, et al.
Bjpsych Open|March 31, 2017
Subclinical psychotic experiences and subsequent contact with mental health servicesVishal Bhavsar, James H Maccabe, Stephani L Hatch, et al.
Therapeutic Advances in Psychopharmacology|March 4, 2017
Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unitSiobhan H Gee, David M Taylor, Sukhwinder S Shergill, et al.
BMC Psychiatry|June 8, 2023
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropeniaEbenezer Oloyede, Danielle Dunnett, David Taylor, et al.
Journal of Psychopharmacology (Oxford, England)|June 13, 2022
Prescribing clozapine in the UK: Quality improvement issues identified by clinical auditThomas Re Barnes, James H MacCabe, John M Kane, et al.
Schizophrenia Bulletin|February 11, 2017
Polygenic Risk Score for Schizophrenia and Treatment-Resistant SchizophreniaTheresa Wimberley, Christiane Gasse, Sandra Melanie Meier, et al.
Journal of Clinical Psychopharmacology|July 31, 2018
Hepatitis, Interstitial Nephritis, and Pancreatitis in Association With Clozapine Treatment: A Systematic Review of Case Series and ReportsJohn Lally, Hana Al Kalbani, Amir Krivoy, et al.
The Lancet. Psychiatry|February 29, 2016
Predictors of treatment resistance in patients with schizophrenia: a population-based cohort studyTheresa Wimberley, Henrik Støvring, Holger J Sørensen, et al.
Translational Psychiatry|December 9, 2020
Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adultsAdrianna P Kępińska, James H MacCabe, Dorina Cadar, et al.
Schizophrenia Bulletin|June 1, 2019
Clozapine Treatment and Offending: A Within-Subject Study of Patients With Psychotic Disorders in SwedenVishal Bhavsar, Kyriaki Kosidou, Linnea Widman, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Journal of the American Academy of Child and Adolescent Psychiatry|April 25, 2012
Advancing maternal age is associated with increasing risk for autism: a review and meta-analysisSven Sandin, Christina M Hultman, Alexander Kolevzon, et al.
Bjpsych Open|March 31, 2017
Subclinical psychotic experiences and subsequent contact with mental health servicesVishal Bhavsar, James H Maccabe, Stephani L Hatch, et al.
Therapeutic Advances in Psychopharmacology|March 4, 2017
Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unitSiobhan H Gee, David M Taylor, Sukhwinder S Shergill, et al.
BMC Psychiatry|June 8, 2023
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropeniaEbenezer Oloyede, Danielle Dunnett, David Taylor, et al.
Journal of Psychopharmacology (Oxford, England)|June 13, 2022
Prescribing clozapine in the UK: Quality improvement issues identified by clinical auditThomas Re Barnes, James H MacCabe, John M Kane, et al.
Schizophrenia Bulletin|February 11, 2017
Polygenic Risk Score for Schizophrenia and Treatment-Resistant SchizophreniaTheresa Wimberley, Christiane Gasse, Sandra Melanie Meier, et al.
Journal of Clinical Psychopharmacology|July 31, 2018
Hepatitis, Interstitial Nephritis, and Pancreatitis in Association With Clozapine Treatment: A Systematic Review of Case Series and ReportsJohn Lally, Hana Al Kalbani, Amir Krivoy, et al.
The Lancet. Psychiatry|February 29, 2016
Predictors of treatment resistance in patients with schizophrenia: a population-based cohort studyTheresa Wimberley, Henrik Støvring, Holger J Sørensen, et al.
Translational Psychiatry|December 9, 2020
Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adultsAdrianna P Kępińska, James H MacCabe, Dorina Cadar, et al.
Schizophrenia Bulletin|June 1, 2019
Clozapine Treatment and Offending: A Within-Subject Study of Patients With Psychotic Disorders in SwedenVishal Bhavsar, Kyriaki Kosidou, Linnea Widman, et al.
Pageof 16